Page last updated: 2024-08-17

medroxyprogesterone acetate and Cancer of the Thyroid

medroxyprogesterone acetate has been researched along with Cancer of the Thyroid in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kurebayashi, J; Moriya, T; Otsuki, T; Sonoo, H; Tanaka, K; Yamamoto, Y1

Other Studies

1 other study(ies) available for medroxyprogesterone acetate and Cancer of the Thyroid

ArticleYear
Medroxyprogesterone acetate decreases secretion of interleukin-6 and parathyroid hormone-related protein in a new anaplastic thyroid cancer cell line, KTC-2.
    Thyroid : official journal of the American Thyroid Association, 2003, Volume: 13, Issue:3

    Topics: Carcinoma, Papillary; Cell Line, Tumor; Dexamethasone; Dihydrotestosterone; DNA Primers; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-6; Medroxyprogesterone Acetate; Microscopy, Phase-Contrast; Parathyroid Hormone-Related Protein; Progesterone; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger; Secretory Rate; Thyroglobulin; Thyroid Neoplasms

2003